Ligand validation:3AK4

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3AK4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AK4_NAD_C_903	95%	40%	0.072	0.977	0.89	1.42	2	8	0	0	100%	1
3AK4_NAD_A_901	94%	39%	0.077	0.974	0.94	1.44	1	7	0	0	100%	1
3AK4_NAD_B_902	81%	43%	0.103	0.955	0.96	1.22	3	6	0	0	100%	1
3AK4_NAD_D_904	65%	42%	0.131	0.932	0.95	1.3	1	4	0	0	100%	1
3WDS_NAD_C_301	84%	22%	0.094	0.957	1.48	1.77	5	12	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.